nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Anaemia—Altretamine—ovarian cancer	0.0214	0.0214	CcSEcCtD
Pasireotide—Vertigo—Altretamine—ovarian cancer	0.0208	0.0208	CcSEcCtD
Pasireotide—Sinus bradycardia—Paclitaxel—ovarian cancer	0.0196	0.0196	CcSEcCtD
Pasireotide—Blood glucose increased—Paclitaxel—ovarian cancer	0.0188	0.0188	CcSEcCtD
Pasireotide—Decreased appetite—Altretamine—ovarian cancer	0.0164	0.0164	CcSEcCtD
Pasireotide—Injection site reaction—Melphalan—ovarian cancer	0.0163	0.0163	CcSEcCtD
Pasireotide—Fatigue—Altretamine—ovarian cancer	0.0163	0.0163	CcSEcCtD
Pasireotide—Injection site reaction—Vinorelbine—ovarian cancer	0.0142	0.0142	CcSEcCtD
Pasireotide—Asthenia—Altretamine—ovarian cancer	0.0135	0.0135	CcSEcCtD
Pasireotide—Prothrombin level increased—Epirubicin—ovarian cancer	0.0134	0.0134	CcSEcCtD
Pasireotide—Dizziness—Altretamine—ovarian cancer	0.0125	0.0125	CcSEcCtD
Pasireotide—Prothrombin level increased—Doxorubicin—ovarian cancer	0.0124	0.0124	CcSEcCtD
Pasireotide—Vomiting—Altretamine—ovarian cancer	0.012	0.012	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Paclitaxel—ovarian cancer	0.0117	0.0117	CcSEcCtD
Pasireotide—Nausea—Altretamine—ovarian cancer	0.0112	0.0112	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.0109	0.0109	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.0107	0.0107	CcSEcCtD
Pasireotide—Injection site reaction—Paclitaxel—ovarian cancer	0.00958	0.00958	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.00936	0.00936	CcSEcCtD
Pasireotide—Alopecia—Chlorambucil—ovarian cancer	0.00835	0.00835	CcSEcCtD
Pasireotide—Injection site reaction—Docetaxel—ovarian cancer	0.00812	0.00812	CcSEcCtD
Pasireotide—Anaemia—Chlorambucil—ovarian cancer	0.0076	0.0076	CcSEcCtD
Pasireotide—Alopecia—Topotecan—ovarian cancer	0.00743	0.00743	CcSEcCtD
Pasireotide—Alopecia—Melphalan—ovarian cancer	0.00728	0.00728	CcSEcCtD
Pasireotide—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00717	0.00717	CcSEcCtD
Pasireotide—Back pain—Topotecan—ovarian cancer	0.00708	0.00708	CcSEcCtD
Pasireotide—Pain in extremity—Paclitaxel—ovarian cancer	0.00699	0.00699	CcSEcCtD
Pasireotide—Anaemia—Topotecan—ovarian cancer	0.00677	0.00677	CcSEcCtD
Pasireotide—Anaemia—Melphalan—ovarian cancer	0.00662	0.00662	CcSEcCtD
Pasireotide—Dry skin—Paclitaxel—ovarian cancer	0.00641	0.00641	CcSEcCtD
Pasireotide—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00639	0.00639	CcSEcCtD
Pasireotide—Hypokalaemia—Paclitaxel—ovarian cancer	0.00637	0.00637	CcSEcCtD
Pasireotide—Alopecia—Vinorelbine—ovarian cancer	0.00636	0.00636	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.0063	0.0063	CcSEcCtD
Pasireotide—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00625	0.00625	CcSEcCtD
Pasireotide—Myalgia—Topotecan—ovarian cancer	0.00623	0.00623	CcSEcCtD
Pasireotide—Arthralgia—Topotecan—ovarian cancer	0.00623	0.00623	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.00617	0.00617	CcSEcCtD
Pasireotide—Myalgia—Melphalan—ovarian cancer	0.0061	0.0061	CcSEcCtD
Pasireotide—Abdominal distension—Paclitaxel—ovarian cancer	0.00609	0.00609	CcSEcCtD
Pasireotide—Back pain—Vinorelbine—ovarian cancer	0.00606	0.00606	CcSEcCtD
Pasireotide—Influenza—Paclitaxel—ovarian cancer	0.00604	0.00604	CcSEcCtD
Pasireotide—Pain in extremity—Docetaxel—ovarian cancer	0.00593	0.00593	CcSEcCtD
Pasireotide—Decreased appetite—Chlorambucil—ovarian cancer	0.00583	0.00583	CcSEcCtD
Pasireotide—Anaemia—Vinorelbine—ovarian cancer	0.00579	0.00579	CcSEcCtD
Pasireotide—Fatigue—Chlorambucil—ovarian cancer	0.00579	0.00579	CcSEcCtD
Pasireotide—Vertigo—Vinorelbine—ovarian cancer	0.00563	0.00563	CcSEcCtD
Pasireotide—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00549	0.00549	CcSEcCtD
Pasireotide—Injection site reaction—Epirubicin—ovarian cancer	0.00548	0.00548	CcSEcCtD
Pasireotide—Hypotension—Melphalan—ovarian cancer	0.00547	0.00547	CcSEcCtD
Pasireotide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00545	0.00545	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00544	0.00544	CcSEcCtD
Pasireotide—Dry skin—Docetaxel—ovarian cancer	0.00543	0.00543	CcSEcCtD
Pasireotide—Abdominal pain upper—Docetaxel—ovarian cancer	0.00541	0.00541	CcSEcCtD
Pasireotide—Hypertension—Vinorelbine—ovarian cancer	0.00541	0.00541	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00534	0.00534	CcSEcCtD
Pasireotide—Arthralgia—Vinorelbine—ovarian cancer	0.00533	0.00533	CcSEcCtD
Pasireotide—Myalgia—Vinorelbine—ovarian cancer	0.00533	0.00533	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00533	0.00533	CcSEcCtD
Pasireotide—Abdominal pain—Chlorambucil—ovarian cancer	0.0053	0.0053	CcSEcCtD
Pasireotide—Nasopharyngitis—Docetaxel—ovarian cancer	0.0053	0.0053	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00523	0.00523	CcSEcCtD
Pasireotide—Decreased appetite—Topotecan—ovarian cancer	0.00519	0.00519	CcSEcCtD
Pasireotide—Fatigue—Topotecan—ovarian cancer	0.00515	0.00515	CcSEcCtD
Pasireotide—Constipation—Topotecan—ovarian cancer	0.00511	0.00511	CcSEcCtD
Pasireotide—Decreased appetite—Melphalan—ovarian cancer	0.00509	0.00509	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—ovarian cancer	0.00507	0.00507	CcSEcCtD
Pasireotide—Fatigue—Melphalan—ovarian cancer	0.00504	0.00504	CcSEcCtD
Pasireotide—Gastrointestinal pain—Topotecan—ovarian cancer	0.00489	0.00489	CcSEcCtD
Pasireotide—Asthenia—Chlorambucil—ovarian cancer	0.00481	0.00481	CcSEcCtD
Pasireotide—Hypotension—Vinorelbine—ovarian cancer	0.00478	0.00478	CcSEcCtD
Pasireotide—Oedema peripheral—Paclitaxel—ovarian cancer	0.00477	0.00477	CcSEcCtD
Pasireotide—Pruritus—Chlorambucil—ovarian cancer	0.00475	0.00475	CcSEcCtD
Pasireotide—Abdominal pain—Topotecan—ovarian cancer	0.00472	0.00472	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00466	0.00466	CcSEcCtD
Pasireotide—Diabetes mellitus—Epirubicin—ovarian cancer	0.0046	0.0046	CcSEcCtD
Pasireotide—Diarrhoea—Chlorambucil—ovarian cancer	0.00459	0.00459	CcSEcCtD
Pasireotide—Decreased appetite—Vinorelbine—ovarian cancer	0.00444	0.00444	CcSEcCtD
Pasireotide—Fatigue—Vinorelbine—ovarian cancer	0.00441	0.00441	CcSEcCtD
Pasireotide—Constipation—Vinorelbine—ovarian cancer	0.00437	0.00437	CcSEcCtD
Pasireotide—Asthenia—Topotecan—ovarian cancer	0.00429	0.00429	CcSEcCtD
Pasireotide—Alopecia—Paclitaxel—ovarian cancer	0.00428	0.00428	CcSEcCtD
Pasireotide—Vomiting—Chlorambucil—ovarian cancer	0.00427	0.00427	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00425	0.00425	CcSEcCtD
Pasireotide—Pruritus—Topotecan—ovarian cancer	0.00423	0.00423	CcSEcCtD
Pasireotide—Asthenia—Melphalan—ovarian cancer	0.0042	0.0042	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00418	0.00418	CcSEcCtD
Pasireotide—Pruritus—Melphalan—ovarian cancer	0.00414	0.00414	CcSEcCtD
Pasireotide—Hypoglycaemia—Epirubicin—ovarian cancer	0.0041	0.0041	CcSEcCtD
Pasireotide—Diarrhoea—Topotecan—ovarian cancer	0.00409	0.00409	CcSEcCtD
Pasireotide—Back pain—Paclitaxel—ovarian cancer	0.00407	0.00407	CcSEcCtD
Pasireotide—Abdominal pain—Vinorelbine—ovarian cancer	0.00404	0.00404	CcSEcCtD
Pasireotide—Oedema peripheral—Docetaxel—ovarian cancer	0.00404	0.00404	CcSEcCtD
Pasireotide—Diarrhoea—Melphalan—ovarian cancer	0.004	0.004	CcSEcCtD
Pasireotide—Pain in extremity—Epirubicin—ovarian cancer	0.004	0.004	CcSEcCtD
Pasireotide—Nausea—Chlorambucil—ovarian cancer	0.00399	0.00399	CcSEcCtD
Pasireotide—Dizziness—Topotecan—ovarian cancer	0.00395	0.00395	CcSEcCtD
Pasireotide—Anaemia—Paclitaxel—ovarian cancer	0.00389	0.00389	CcSEcCtD
Pasireotide—Vomiting—Topotecan—ovarian cancer	0.0038	0.0038	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00379	0.00379	CcSEcCtD
Pasireotide—Vertigo—Paclitaxel—ovarian cancer	0.00378	0.00378	CcSEcCtD
Pasireotide—Headache—Topotecan—ovarian cancer	0.00374	0.00374	CcSEcCtD
Pasireotide—Vomiting—Melphalan—ovarian cancer	0.00372	0.00372	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—ovarian cancer	0.0037	0.0037	CcSEcCtD
Pasireotide—Asthenia—Vinorelbine—ovarian cancer	0.00367	0.00367	CcSEcCtD
Pasireotide—Dry skin—Epirubicin—ovarian cancer	0.00367	0.00367	CcSEcCtD
Pasireotide—Abdominal pain upper—Epirubicin—ovarian cancer	0.00365	0.00365	CcSEcCtD
Pasireotide—Hypokalaemia—Epirubicin—ovarian cancer	0.00364	0.00364	CcSEcCtD
Pasireotide—Hypertension—Paclitaxel—ovarian cancer	0.00364	0.00364	CcSEcCtD
Pasireotide—Alopecia—Docetaxel—ovarian cancer	0.00362	0.00362	CcSEcCtD
Pasireotide—Pruritus—Vinorelbine—ovarian cancer	0.00362	0.00362	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.0036	0.0036	CcSEcCtD
Pasireotide—Arthralgia—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Pasireotide—Myalgia—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Pasireotide—Nasopharyngitis—Epirubicin—ovarian cancer	0.00358	0.00358	CcSEcCtD
Pasireotide—Anxiety—Paclitaxel—ovarian cancer	0.00357	0.00357	CcSEcCtD
Pasireotide—Nausea—Topotecan—ovarian cancer	0.00355	0.00355	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Pasireotide—Diarrhoea—Vinorelbine—ovarian cancer	0.0035	0.0035	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—ovarian cancer	0.00348	0.00348	CcSEcCtD
Pasireotide—Nausea—Melphalan—ovarian cancer	0.00347	0.00347	CcSEcCtD
Pasireotide—Influenza—Epirubicin—ovarian cancer	0.00346	0.00346	CcSEcCtD
Pasireotide—Back pain—Docetaxel—ovarian cancer	0.00345	0.00345	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—ovarian cancer	0.00339	0.00339	CcSEcCtD
Pasireotide—Dizziness—Vinorelbine—ovarian cancer	0.00338	0.00338	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00338	0.00338	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—ovarian cancer	0.00337	0.00337	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00333	0.00333	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00331	0.00331	CcSEcCtD
Pasireotide—Anaemia—Docetaxel—ovarian cancer	0.0033	0.0033	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Pasireotide—Vomiting—Vinorelbine—ovarian cancer	0.00325	0.00325	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—ovarian cancer	0.00322	0.00322	CcSEcCtD
Pasireotide—Hypotension—Paclitaxel—ovarian cancer	0.00321	0.00321	CcSEcCtD
Pasireotide—Headache—Vinorelbine—ovarian cancer	0.0032	0.0032	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—ovarian cancer	0.0032	0.0032	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00313	0.00313	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00312	0.00312	CcSEcCtD
Pasireotide—Insomnia—Paclitaxel—ovarian cancer	0.00311	0.00311	CcSEcCtD
Pasireotide—Hypertension—Docetaxel—ovarian cancer	0.00308	0.00308	CcSEcCtD
Pasireotide—Arthralgia—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Pasireotide—Myalgia—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Pasireotide—Nausea—Vinorelbine—ovarian cancer	0.00304	0.00304	CcSEcCtD
Pasireotide—Decreased appetite—Paclitaxel—ovarian cancer	0.00299	0.00299	CcSEcCtD
Pasireotide—Fatigue—Paclitaxel—ovarian cancer	0.00296	0.00296	CcSEcCtD
Pasireotide—Constipation—Paclitaxel—ovarian cancer	0.00294	0.00294	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00288	0.00288	CcSEcCtD
Pasireotide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00281	0.00281	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—ovarian cancer	0.00272	0.00272	CcSEcCtD
Pasireotide—Hypotension—Docetaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Pasireotide—Abdominal pain—Paclitaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00265	0.00265	CcSEcCtD
Pasireotide—Insomnia—Docetaxel—ovarian cancer	0.00264	0.00264	CcSEcCtD
Pasireotide—Decreased appetite—Docetaxel—ovarian cancer	0.00253	0.00253	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Pasireotide—Fatigue—Docetaxel—ovarian cancer	0.00251	0.00251	CcSEcCtD
Pasireotide—Constipation—Docetaxel—ovarian cancer	0.00249	0.00249	CcSEcCtD
Pasireotide—Asthenia—Paclitaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—ovarian cancer	0.00244	0.00244	CcSEcCtD
Pasireotide—Pruritus—Paclitaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Pasireotide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00238	0.00238	CcSEcCtD
Pasireotide—Diarrhoea—Paclitaxel—ovarian cancer	0.00235	0.00235	CcSEcCtD
Pasireotide—Back pain—Epirubicin—ovarian cancer	0.00233	0.00233	CcSEcCtD
Pasireotide—Abdominal pain—Docetaxel—ovarian cancer	0.0023	0.0023	CcSEcCtD
Pasireotide—Dizziness—Paclitaxel—ovarian cancer	0.00227	0.00227	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—ovarian cancer	0.00226	0.00226	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—ovarian cancer	0.00223	0.00223	CcSEcCtD
Pasireotide—Vomiting—Paclitaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Pasireotide—Vertigo—Epirubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Pasireotide—Headache—Paclitaxel—ovarian cancer	0.00215	0.00215	CcSEcCtD
Pasireotide—Asthenia—Docetaxel—ovarian cancer	0.00209	0.00209	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—ovarian cancer	0.00208	0.00208	CcSEcCtD
Pasireotide—Pruritus—Docetaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—ovarian cancer	0.00206	0.00206	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Pasireotide—Nausea—Paclitaxel—ovarian cancer	0.00204	0.00204	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—ovarian cancer	0.002	0.002	CcSEcCtD
Pasireotide—Diarrhoea—Docetaxel—ovarian cancer	0.00199	0.00199	CcSEcCtD
Pasireotide—Dizziness—Docetaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—ovarian cancer	0.00192	0.00192	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Pasireotide—Vomiting—Docetaxel—ovarian cancer	0.00185	0.00185	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—ovarian cancer	0.00184	0.00184	CcSEcCtD
Pasireotide—Headache—Docetaxel—ovarian cancer	0.00183	0.00183	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Pasireotide—Nausea—Docetaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—ovarian cancer	0.00169	0.00169	CcSEcCtD
Pasireotide—Constipation—Epirubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Pasireotide—Headache—Epirubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Pasireotide—Nausea—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Pasireotide—Headache—Doxorubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Pasireotide—Nausea—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
